Pharmacists' perceptions of advancing public health priorities through medication therapy management

Keywords: Medication Therapy Management, Pharmaceutical Services, Public Health Practice, Health Knowledge, Attitudes, Practice, Attitude of Health Personnel, Pharmacists, United States


Background: Public health priorities can be addressed by pharmacists through channels such as medication therapy management (MTM) to optimize patient and population outcomes. However, no studies have specifically assessed pharmacists’ perceptions of addressing public health priorities through MTM.

Objective: The objective of this study was to assess pharmacists’ opinions regarding the feasibility and appropriateness of addressing seven areas of public health priority through MTM services to impact public health in direct patient care settings.

Methods: An anonymous 37-question electronic survey was conducted to evaluate Ohio pharmacists’ opinions of advancing seven public health priorities identified from Healthy People 2020 (family planning, preconception care, smoking cessation, immunizations, nutrition/biometric wellness assessments, point-of-care testing, fall prevention) through MTM activities; to identify potential barriers; and to collect demographic information. The cross-sectional survey was sent to a random sample of 500 pharmacists registered with the Ohio State Board of Pharmacy.

Results: Seventy-six pharmacists responded to the survey, resulting in a 16% response rate. On average, it took respondents 5-10 minutes to complete the survey. The majority of respondents thought that each of the seven public health priorities were “important” or “very important” to patient health; the most commonly identified areas included smoking cessation, immunizations, and fall prevention (97.5%). When asked to indicate which of the seven areas they thought they could potentially have a role to provide services through MTM, on average pharmacists picked 4 of the priority areas. Only 6.6% indicated there was no role for pharmacists to provide MTM services for any of the listed categories. Staffing, time, and reimbursement represented the most commonly perceived barriers for pharmacists in providing MTM services. Fifty-seven percent indicated an interest in learning more about MTM, with 98% of responders selecting continuing education as the preferred source.

Conclusion: The majority of pharmacists indicated they could make an impact on public health priorities through MTM services.


Download data is not yet available.

Author Biographies

Lucas M. Casserlie
Doctor of pharmacy candidate
Natalie A. DiPietro Mager
Associate Professor of Pharmacy Practice


1. American Public Health Association. The role of the pharmacist in public health. Available at: (accessed 2016 Feb 24).

2. U.S. Department of Health and Human Services. Healthy People 2020. Available at: (accessed 2016 Feb 24).

3. DeArment A. Pharmacists are face of health care in community. Available at: (accessed 2016 Feb 24).

4. National Association of Chain Drug Stores. Meeting payer needs for pharmacist-provided services: The time is now. Available at: (accessed 2016 Feb 24).

5. American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model, version 2.0. 2008. Available at: (accessed 2016 Feb 24).

6. Center for Medicare, U.S. Department of Health and Human Services. Contract year 2016 medication therapy management program guidance and submission instructions. Available at: (accessed 2016 Feb 24).

7. American Pharmacists Association. Washington state implements Medicaid managed care MTM law for 2015. Available at: (accessed 2016 Feb 24).

8. Vyzral K. CareSource announces payment for pharmacist-provided MTM for Ohio Medicaid patients. Ohio Pharmacist 2012;61(9):14.

9. Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices among pharmacists. J Am Pharm Assoc (Wash). 2000;40(6):773-779.

10. Calis KA, Hutchison LC, Elliott ME, Ives TJ, Zillich AJ, Poirier T, Townsend KA, Woodall B, Feldman S, Raebel MA, American College of Clinical Pharmacy. Healthy People 2010: challenges, opportunities, and a call to action for America’s pharmacists. Pharmacotherapy. 2004;24(9):1241-1294.

11. Hazelet E, Oliver A, Salay K, Rizzo B, Huet A, DiPietro N. Healthy People 2020: identifying roles for pharmacists in public health. Pharm Wellness Rev. 2011;2(2):16-21.

12. Ahlquist GD, Javanmardian M, Kaura A, Bilokrynytskyy I. The pharmacy solution: an expanding role for pharmacies in healthcare delivery. Available at: (accessed 2016 Feb 24).

13. Centers for Disease Control and Prevention. Partnering with pharmacists in the prevention and control of chronic diseases. Available at: (accessed 2016 Feb 24).

14. Giberson S, Yoder S, Lee MP. Improving patient and health system outcomes through advanced pharmacy practice: a report to the U.S. Surgeon General. Office of the Chief Pharmacist. U.S. Public Health Service. Dec 2011.

15. Shah M. Expanding the pharmacist's role in MTM services. Drug Topics. Available from: (accessed 2016 Feb 24).

16. Lynum KS, Hill AM. Psychiatric services: a platform for MTM. J Pharm Pract. 2015;28(1):13-20. doi: 10.1177/0897190014562352

17. Schuh MJ. Creation of a bariatric surgery medication therapy management model. Consult Pharm. 2015 Jul;30(7):403-406. doi: 10.4140/TCP.n.2015.403

18. Smalls TD, Broughton AD, Hylick EV, Woodard TJ. Providing medication therapy management for smoking cessation patients. J Pharm Pract. 2015;28(1):21-25. doi: 10.1177/0897190014562381

19. Haga SB, Allen LaPointe NM. Moaddeb J, Mills R, Patel M, Kraus WE. Pilot study: incorporation of pharmacogenetic testing in medication therapy management services. Pharmacogenomics. 2014;15(14):1729-1737.

20. DiPietro NA, Bright DR. Medication therapy management and preconception care: opportunities for pharmacist intervention. Innov Pharm. 2014;5(1):141.

21. Mott DA, Martin B, Breslow R, Michaels B, Kirchner J, Mahoney J, Margolis A. Impact of a medication therapy management intervention targeting medications associated with falling: Results of a pilot study. J Am Pharm Assoc (2003). 2016;56(1):22-28. doi: 10.1016/j.japh.2015.11.001

22. Darin KM, Klepser ME, Klepser DE, Klepser SA, Reeves A, Young M, Scarsi KK. Pharmacist-provided rapid HIV testing in two community pharmacies. J Am Pharm Assoc (2003). 2015;55(1):81-88. doi: 10.1331/JAPhA.2015.14070

23. Weidle PJ, Lecher S, Botts LW, Jones L, Spach DH, Alvarez J, Jones R, Thomas V. HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection. J Am Pharm Assoc (2003). 2014;54(5):486-492. doi: 10.1331/JAPhA.2014.14045

24. Blazejewski L, Vaidya V, Pinto S, Gaither C. Pharmacists’ perceived barriers providing non-dispensing services to underserved populations. J Community Health. 2013;38(5):812-822. doi: 10.1007/s10900-013-9682-0

25. Pace AC, Flowers SK, Hastings JK. Arkansas community pharmacists’ opinions on providing immunizations. J Pharm Pract. 2010;23(5):496-501. doi: 10.1177/0897190010362105

26. Hudmon KS, Prokhorov AV, Corelli RL. Tobacco cessation counseling: pharmacists’ opinions and practices. Patient Educ Couns. 2006;61(1):152-160.
Original Research